Cargando…
SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
As of September 2021, there has been a total of 123,633 confirmed cases of pregnant women with SARS-CoV-2 infection in the US according to the CDC, with maternal death being 2.85 times more likely, pre-eclampsia 1.33 times more likely, preterm birth 1.47 times more likely, still birth 2.84 times mor...
Autores principales: | Rangchaikul, Patrida, Venketaraman, Vishwanath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700906/ https://www.ncbi.nlm.nih.gov/pubmed/34940401 http://dx.doi.org/10.3390/idr13040091 |
Ejemplares similares
-
Review of Pediatric Tuberculosis in the Aftermath of COVID-19
por: Rangchaikul, Patrida, et al.
Publicado: (2022) -
Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections
por: Orujyan, Davit, et al.
Publicado: (2022) -
The effect of the delta SARS-CoV-2 variant on maternal infection and pregnancy
por: Samara, Athina, et al.
Publicado: (2022) -
Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection
por: Singh, Manpreet, et al.
Publicado: (2022) -
Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
por: Chaudhari, Armi M., et al.
Publicado: (2022)